The first test that can simultaneously detect 11 common viral, bacterial, and parasitic causes of infectious gastroenteritis from a single patient sample has been cleared for marketing by the US Food ...

Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance to add three new targets to its xTAG® Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, ...

Luminex xTAG® Gastrointestinal Pathogen Panel (GPP) delivers clinically actionable results in time to affect patient care Infectious gastroenteritis strikes more than two billion times globally each ...

Australia’s Golden Gate Petroleum is set to start production testing at the Jumonville-2 exploration/appraisal well at the Bullseye prospect in the US state of Louisiana this week-end. The well has ...

Please provide your email address to receive an email when new articles are posted on . Luminex has received FDA approval to add three new targets to its xTAG Gastrointestinal Pathogen Panel, ...

AUSTIN, Texas and MILAN, May 5, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has received CE marking for its new xTAG Gastrointestinal Pathogen Panel (GPP).This ...